PNG logo About ADC Therapeutics ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d rendering ADC abstract letter logo design. This logo is designed by three abstract letters.

We are advancing enhanced antibody-drug conjugate, immuno-oncology conjugate and bispecific candidates as potential treatments for cancer. Pipeline Expanded Genetic Code Technology Platform

ADC Therapeutics is a commercial-stage oncology-focused biotechnology company developing ADCs for patients with hematological malignancies & solid tumors.

ADC Therapeutics is a commercial-stage oncology-focused biotechnology company developing ADCs for patients with hematological malignancies & solid tumors.

ADCs are complex molecules composed of an antibody linked to a biologically active cytotoxic or anticancer payload or drug. Examples of bioconjugates and immunoconjugate. 3d rendering. Letters ADC, A D C logo icon with business card vector template. Digital signal processing converter from analog microphone to speakers outline diagram.

Media in category "Antibody-drug conjugates" The following 29 files are in this category, out of 29 total. Antibody oligonucleotide conjugate.png 742 × 530; 380 KB. Antibody-drug conjugate structure-ar.svg 512 × 421; 122 KB. Antibody-drug conjugate structure.svg 512 × 421; 76 KB. Antibody-drug conjugate.png 2,744 × 2,383; 596 KB.

Find the ADC antibody that fits your needs. Choose from 1 of 9 ADC antibodies, which have been validated in experiments with 18 images featured in our data gallery. Browse primary antibodies for WB, Flow, IHC, ICC/IF, ELISA, IP, and other applications.

2024年10月8日 · Antibody-drug conjugates (ADCs) represent an an exciting new drug modality, directing anticancer therapeutics to malignant cells overexpressing particular surface antigens. 10+ ADCs are approved for clinical use, with many more in clinical testing for solid tumors as well as hematologic malignancies.

2 天之前 · DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development PR Newswire Thu, Feb 13, 2025, 12:40 AM 1 min read